US biopharma Mineralys Therapeutics has announced positive topline data from its Phase II Explore-CKD trial evaluating the ...

US pharma major AbbVie (NYSE: ABBV) today announced positive top-line results from its Phase III TEMPLE multicenter, ...

EY today released its 35th annual Biotech Beyond Borders Report. This finds that the biopharma industry is currently at an ...

The UK’s National Institute for Health and Care Excellence (NICE) has today recommended Spevigo (spesolimab) for the ...

The US Food and Drug Administration has announced the Commissioner’s National Priority Voucher (CNPV) program aimed at ...

Draig Therapeutics, a clinical-stage company based in Cardiff, UK, and aiming to transform the treatment of neuropsychiatric ...

US pharma firm Lisata Therapeutics (Nasdaq: LSTA) has teamed up with tech-bio company GATC Health in a strategic alliance ...

Japanese companies Axcelead and A2 Healthcare Corporation announced that they will enter a strategic partnership to promote ...

US biotech Dyne Therapeutics (Nasdaq: DYN) has revised its regulatory approach for DYNE-101, a treatment in development for ...

Japanese companies NEC Corporation and Chugai Pharmaceutical have entered a collaboration to conduct an experiment using AI ...

A controversial proposal to change the Inflation Reduction Act’s pricing framework for rare disease drugs has been dropped ...

Chinese biotech start-up BioTroy Therapeutics has raised over 200 million renmnibi ($28 million) in series A financing to advance clinical trials for its experimental immunotherapy targeting CD3L1, a ...